The Results of Ahmed Valve Operations
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00193960|
Recruitment Status : Unknown
Verified September 2005 by University Health Network, Toronto.
Recruitment status was: Recruiting
First Posted : September 19, 2005
Last Update Posted : December 1, 2005
|Condition or disease||Intervention/treatment|
|Glaucoma||Procedure: 1) Intraocular pressure 2) visual acuity|
Glaucoma drainage devices are usually placed in the superior quadrants. The superotemporal quadrant is usually the site of choice. However, when the upper fornix is scarred and especially when conjunctiva is two fibrotic to enable adequate coverage of tube with a scleral or other patch graft, some surgeons place the tube in one of inferior quadrants.
In the present study we will compare the outcome and complicatons of both the superior and the inferior approach for inserting Ahmed Valve implants.
|Study Type :||Observational|
|Enrollment :||80 participants|
|Observational Model:||Defined Population|
|Official Title:||A Comparison Between Superior and Inferior Ahmed Glaucoma Valve Implantation: Surgical Success and Complications|
|Study Start Date :||January 1997|
|Study Completion Date :||June 2005|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00193960
|Contact: Rony Rachmiel, M.D.||firstname.lastname@example.org|
|Department of Ophthalmology and visual sciences, Toronto Western Hospital,||Recruiting|
|Toronto, Ontario, Canada|
|Contact: Rony Rachmiel, MD 416-603-5317 email@example.com|
|Principal Investigator: Graham E Trope, MB, FRCSC|
|Sub-Investigator: Rony Rachmiel, MD|
|Sub-Investigator: Yvonne M Buys, M.D., FRCSC|
|Sub-Investigator: Flanagan John, Phd|
|Study Director:||Trope E Graham, MB, FRCSC||University of Toronto, Department of Ophthalmology|
|Study Director:||Rony Rachmiel, M.D||University of Toronto, Department of Ophthalmology|